Frontiers in Drug Discovery is a peer-reviewed english-language open-access journal published by Frontiers Media S.A. in Switzerland, operating under an open-access model since 2021. The journal covers Therapeutics. Pharmacology.
Authors are required to pay an article processing charge to publish in Frontiers in Drug Discovery; refer to the journal's APC page for the current rate. A waiver policy is offered for eligible authors. Articles are released under the CC BY license (see other journals using this license).
All submissions undergo plagiarism screening before peer review.
Keywords
pharmacology, basic pharmacology, bioinformatics, cheminformatics, cardiology, clinical pharmacology
At a glance
- Publisher
- Frontiers Media S.A.
- Country
- Switzerland
- Primary language
- English
- License
- CC BY
- Peer review
- Anonymous peer review
- OA since
- 2021
- Review time
- 15 weeks
- Plagiarism check
- Yes
ISSN
- electronic
- 2674-0338
Frequently asked questions
Is Frontiers in Drug Discovery peer-reviewed?
Yes — Frontiers in Drug Discovery operates a Anonymous peer review review process.
Does Frontiers in Drug Discovery charge an article processing charge (APC)?
Yes — refer to the journal's APC page for the current rate. A waiver policy is available for eligible authors.
What subjects does Frontiers in Drug Discovery publish?
Frontiers in Drug Discovery publishes research in Therapeutics. Pharmacology.
What languages does Frontiers in Drug Discovery accept?
Frontiers in Drug Discovery accepts manuscripts in English.
What is the ISSN of Frontiers in Drug Discovery?
ISSN:
2674-0338 (electronic).How do I submit a manuscript to Frontiers in Drug Discovery?
Submit through the journal's official portal: visit submission page →
How long does peer review take at Frontiers in Drug Discovery?
Average time from submission to publication is approximately 15 weeks.